Skip to main content
Premium Trial:

Request an Annual Quote

Pressure BioSciences Inks Distribution Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that it has signed a distribution deal with KeraFast, which specializes in selling life science tools through its e-commerce channel.

The agreement covers Pressure Bio's new sample preparation offerings including its Shredder SG3 Extraction System, MicroTube, MicroCap, and PCT Shredder sample processing tubes. It also includes Pressure Bio's kits for preparing samples for DNA, RNA, protein, and lipid analysis.

"KeraFast has developed a successful marketing approach using the power and tremendous reach of e-commerce, which we believe combines well with our traditional marketing approach," Nate Lawrence, VP of marketing for Pressure Bio, said in a statement. "Together, our combined marketing activites should bring greater visibility to PBI and to our sample preparation products, which we believe will result in increased revenue for PBI."

Financial and other terms of the agreement were not disclosed.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.